Skip to main content
OpenTrials

Clinical trial condition

Glomerulonephritis, IGA

Explore clinical trials studying Glomerulonephritis, IGA. Study availability and eligibility vary by location and protocol.

203 public trials 59 recruiting studies
Refine in advanced search Browse all conditions

Glomerulonephritis, IGA trial results

Completed

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

NCT03453619

Conditions
Autoimmune Diseases, C3 Glomerulonephritis, Connective Tissue Diseases, +18 more
Locations
  • Stanford University Stanford, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • HealthONE Physician Care, Rocky Mountain Hospital for Children Denver, Colorado, United States
  • Washington Nephrology Associates Washington D.C., District of Columbia, United States
View all 17 locations
View Trial Details
Completed

Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE)

NCT04541043

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • 13 Investigator sites Palo Alto, California, United States
  • 4 Investigator sites Buenos Aires, Argentina
  • 6 Investigator sites Melbourne, Australia
  • 3 Investigator sites Minsk, Belarus
View all 18 locations
View Trial Details
Completed

A Study to Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA Nephropathy

NCT04014335

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • IONIS Investigative Site Liverpool, New South Wales, Australia
  • IONIS Investigative Site St Leonards, New South Wales, Australia
  • IONIS Investigative Site Parkville, Victoria, Australia
  • IONIS Investigative Site Vancouver, British Columbia, Canada
View Trial Details
Completed

Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy

NCT03643965

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • University of Alabama at Birmingham, 1720 2nd Ave South Birmingham, Alabama, United States
  • Univ of Arizona, 1501 N Campbell Ave Tucson, Arizona, United States
  • Stanford University Medical Center, 777 Welch Rd Palo Alto, California, United States
  • Los Angeles Biomedical Research Institute at HUMC, 1124 W. Carson Street Torrance, California, United States
View all 142 locations
View Trial Details
Completed

Humanistic Burden of (FSGS) Focal Segmental Glomerulosclerosis and IgAN (Immunoglobulin A Nephropathy)

NCT05200871

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Travere Investigational Site San Francisco, California, United States
  • Travere Investigational Site Belmar, New Jersey, United States
  • Travere Investigational Site Chapel Hill, North Carolina, United States
  • Travere Investigational Site King of Prussia, Pennsylvania, United States
View Trial Details

Related conditions